United States Neurological Biomarkers Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
United States Neurological Biomarkers Market
Research and Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "United States Neurological Biomarkers
  Market Industry Trends, Share, Size, Growth,
  Opportunity and Forecast 2024-2032," the United
  States neurological biomarkers market size is
  projected to exhibit a growth rate (CAGR) of
  4.20 during 2024-2032.
• The United States neurological biomarkers market
  is witnessing substantial growth, primarily
  driven by the rising prevalence of neurological
  disorders, including Parkinson's, Alzheimer's,
  and multiple sclerosis. In addition to this, the
  increasing incidence rates of these disorders
  have intensified the need for early diagnosis and
  effective treatment, thereby boosting the demand
  for neurological biomarkers. These biomarkers
  play an important role in identifying the
  beginning and progression of neurological
  diseases, enabling healthcare professionals to
  implement timely and targeted interventions.
• Moreover, advancements in biotechnology and
  genomics have led to the discovery of numerous
  novel biomarkers, which is creating a positive
  outlook for the market. Besides this, the
  integration of artificial intelligence and
  machine learning in the analysis of complex
  neurological data is also propelling the market
  forward, as these technologies improve the
  precision and efficiency of biomarker discovery.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/united-states-neurologi
  cal-biomarkers-market/requestsample

4
Report Description

• United States Neurological Biomarkers Market
  Trends
• Furthermore, the increasing funding and research
  initiatives aimed at understanding and treating
  neurological disorders are augmenting the United
  States neurological biomarkers market.
  Additionally, collaborative efforts between
  research institutions, pharmaceutical companies,
  and government agencies which provide innovative
  approaches to biomarker development and
  validation are also strengthening the market
  growth. Moreover, the elevating awareness of
  mental health and neurological illnesses has
  resulted in faster diagnosis and treatment, which
  is fueling the demand for reliable and accessible
  biomarkers.
• Besides this, the emergence of personalized
  medicine in neurology, where treatment and
  diagnosis are tailored to individual genetic
  profiles, is another key factor driving the
  growth of the market. Furthermore, the ongoing
  research and development, as well as the
  increasing acceptance of precision medicine are
  expected to drive the United States neurological
  biomarkers market in the coming years.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/united-states-neurologi
  cal-biomarkers-market

5
Report Segmentation

• Type Insights
• Genomic Biomarkers
• Proteomic Biomarkers
• Metabolomic Biomarkers
• Imaging Biomarkers
• Others
• Application Insights
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Autism Spectrum Disorders
• Others

6
Report Segmentation

• End Use Insights
• Hospital Laboratories
• Clinical Diagnostic Centers
• Research Organizations
• Others
• Regional Insights
• Northeast
• Midwest
• South
• West

7
Key Questions Answered in the Report
8
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4   United
  States Neurological Biomarkers Market -
  Introduction    4.1    Overview    4.2  
   Market Dynamics    4.3    Industry Trends   
  4.4    Competitive Intelligence5   United States
  Neurological Biomarkers Market Landscape    5.1
     Historical and Current Market Trends
  (2018-2023)    5.2    Market Forecast
  (2024-2032)6   United States Neurological
  Biomarkers Market - Breakup by Type    6.1  
   Genomic Biomarkers        6.1.1 Overview     
    6.1.2 Historical and Current Market Trends
  (2018-2023)        6.1.3 Market Forecast
  (2024-2032)    6.2    Proteomic Biomarkers     
    6.2.1 Overview        6.2.2 Historical and
  Current Market Trends (2018-2023)        6.2.3
  Market Forecast (2024-2032)       

9
Table of Contents

•     6.3    Metabolomic Biomarkers        6.3.1
  Overview        6.3.2 Historical and Current
  Market Trends (2018-2023)        6.3.3 Market
  Forecast (2024-2032)    6.4    Imaging
  Biomarkers        6.4.1 Overview        6.4.2
  Historical and Current Market Trends
  (2018-2023)        6.4.3 Market Forecast
  (2024-2032)    6.5    Others        6.5.1
  Historical and Current Market Trends
  (2018-2023)        6.5.2 Market Forecast
  (2024-2032)7   United States Neurological
  Biomarkers Market - Breakup by Application   
  7.1    Alzheimer's Disease        7.1.1
  Overview        7.1.2 Historical and Current
  Market Trends (2018-2023)        7.1.3 Market
  Forecast (2024-2032)    7.2    Parkinson's
  Disease        7.2.1 Overview        7.2.2
  Historical and Current Market Trends
  (2018-2023)        7.2.3 Market Forecast
  (2024-2032)    7.3    Multiple Sclerosis       
  7.3.1 Overview        7.3.2 Historical and
  Current Market Trends (2018-2023)        7.3.3
  Market Forecast (2024-2032)    7.4    Autism
  Spectrum Disorders        7.4.1 Overview       
  7.4.2 Historical and Current Market Trends
  (2018-2023)        7.4.3 Market Forecast
  (2024-2032)
• For more information, visit https//www.imarcgrou
  p.com/united-states-neurological-biomarkers-market
  /toc

10
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

11
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com